HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

S-Adenosylhomocysteine

Subscribe to New Research on S-Adenosylhomocysteine

5'-S-(3-Amino-3-carboxypropyl)-5'-thioadenosine. Formed from S-adenosylmethionine after transmethylation reactions.

Also Known As:

S Adenosylhomocysteine; Adenosylhomocysteine, S; L-Homocysteine, S-(5'-deoxyadenosin-5'-yl)-

Networked: 159 relevant articles (1 outcomes, 6 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Blom, Henk J: 9 articles (01/2016 - 08/2003)
2.	Wagner, Conrad: 6 articles (01/2015 - 12/2007)
3.	Halsted, Charles H: 6 articles (02/2013 - 05/2004)
4.	Obeid, Rima: 5 articles (05/2014 - 01/2005)
5.	Stabler, Sally P: 5 articles (01/2013 - 02/2004)
6.	Hu, Miao-Lin: 5 articles (12/2011 - 01/2003)
7.	Castro, Rita: 4 articles (01/2016 - 08/2003)
8.	Xia, Min: 4 articles (10/2015 - 02/2008)
9.	Ling, Wenhua: 4 articles (10/2015 - 02/2008)
10.	Allen, Robert H: 4 articles (01/2013 - 02/2004)

Related Diseases

1.	Infection 05/01/1987 - "Treatment of L cells with 5 microM adenosine dialdehyde for 60 min prior to virus infection causes a transient, but virtually complete loss of S-adenosylhomocysteine hydrolase activity and subsequent 3-fold increase in the intracellular S-adenosylhomocysteine/S-adenosylmethionine ratio. " 01/01/2005 - "ampligen); (v) the cloning and expression of interferon-beta, and (vi) its usefulness in the treatment of multiple sclerosis; (vii) the potential of (pegylated) interferon-alpha in the treatment of hepatitis C and (viii) the therapy/prophylaxis of SARS; (ix) the efficacy of interferon (inducers) in the experimental treatment of flavivirus encephalitis and enterovirus myocarditis; and, finally, (x) the role of interferon in the activity shown by S-adenosylhomocysteine inhibitors such as 3-deazaneplanocin A against experimental Ebola virus infections in mice."
2.	Myocarditis (Carditis) 01/01/2005 - "ampligen); (v) the cloning and expression of interferon-beta, and (vi) its usefulness in the treatment of multiple sclerosis; (vii) the potential of (pegylated) interferon-alpha in the treatment of hepatitis C and (viii) the therapy/prophylaxis of SARS; (ix) the efficacy of interferon (inducers) in the experimental treatment of flavivirus encephalitis and enterovirus myocarditis; and, finally, (x) the role of interferon in the activity shown by S-adenosylhomocysteine inhibitors such as 3-deazaneplanocin A against experimental Ebola virus infections in mice."
3.	Multiple Sclerosis 01/01/2005 - "ampligen); (v) the cloning and expression of interferon-beta, and (vi) its usefulness in the treatment of multiple sclerosis; (vii) the potential of (pegylated) interferon-alpha in the treatment of hepatitis C and (viii) the therapy/prophylaxis of SARS; (ix) the efficacy of interferon (inducers) in the experimental treatment of flavivirus encephalitis and enterovirus myocarditis; and, finally, (x) the role of interferon in the activity shown by S-adenosylhomocysteine inhibitors such as 3-deazaneplanocin A against experimental Ebola virus infections in mice."
4.	Hepatitis C 01/01/2005 - "ampligen); (v) the cloning and expression of interferon-beta, and (vi) its usefulness in the treatment of multiple sclerosis; (vii) the potential of (pegylated) interferon-alpha in the treatment of hepatitis C and (viii) the therapy/prophylaxis of SARS; (ix) the efficacy of interferon (inducers) in the experimental treatment of flavivirus encephalitis and enterovirus myocarditis; and, finally, (x) the role of interferon in the activity shown by S-adenosylhomocysteine inhibitors such as 3-deazaneplanocin A against experimental Ebola virus infections in mice."
5.	Encephalitis (Encephalitis, Rasmussen) 01/01/2005 - "ampligen); (v) the cloning and expression of interferon-beta, and (vi) its usefulness in the treatment of multiple sclerosis; (vii) the potential of (pegylated) interferon-alpha in the treatment of hepatitis C and (viii) the therapy/prophylaxis of SARS; (ix) the efficacy of interferon (inducers) in the experimental treatment of flavivirus encephalitis and enterovirus myocarditis; and, finally, (x) the role of interferon in the activity shown by S-adenosylhomocysteine inhibitors such as 3-deazaneplanocin A against experimental Ebola virus infections in mice."

Related Drugs and Biologics

1.	3-deazaneplanocin
2.	Interferons
3.	Interferon-beta
4.	Interferon-alpha (Interferon Alfa)
5.	Interferon Inducers
6.	ampligen
7.	S-Adenosylmethionine (Ademetionine)
8.	Homocysteine
9.	Methionine (L-Methionine)
10.	Adenosine

Related Therapies and Procedures

1.	Vegetarian Diet (Vegetarianism)
2.	Microspheres (Microsphere)